Targeted NAD <sup>+</sup> Delivery for Intimal Hyperplasia and Re-endothelialization: A Novel Anti-restenotic Therapy Approach

Yin Li(Hebei Medical University), Bowen Wang(Northwestern University), Shaoqin Gong(University of Wisconsin–Madison), Nicholas Hoyt(George Washington University), Lian‐Wang Guo(University of Virginia), Eric William Kent(University of Virginia), Zain Husain Islam(University of Virginia), Kaijie Zhang(Northwestern University), Yao Tong(University of Wisconsin–Madison), Sophia Stanisic(University of Virginia), William Aaron Marcum(University of Virginia), Rohan Kanchetty(University of Virginia), Zoe Tetz(University of Virginia), Yitao Huang(University of Virginia), Ruosen Xie(University of Wisconsin–Madison), Campbell Johnston(University of Virginia), Jacobus W. A. Burger(Radboud University Nijmegen)
bioRxiv (Cold Spring Harbor Laboratory)
February 23, 2024
10.1101/2024.02.20.581249
Cited by 0

Related Papers

Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
|˜The œLancet. Gastroenterology & hepatology|2019|326
NAD(H)-loaded nanoparticles for efficient sepsis therapy via modulating immune and vascular homeostasis
|Nature Nanotechnology|2022|150
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)
|BMC Cancer|2019|111
Long-Term Results of Tumor Necrosis Factor α– and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas
|Journal of Clinical Oncology|2011|100
Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections
|Nature Nanotechnology|2024|89